Company: AGIO
Filing Date: 2025-04-25
Form Type: DEF 14A
Source: 0001193125-25-096719
Chunk: 120

Company: AGIOS PHARMACEUTICALS, INC.
Filing Date: 2025-04-25
Form: DEF 14A
Chunk 120
---
 of the Code and incentive stock options, our board of directors may permit or provide in an award for the gratuitous transfer of the award by the participant to or for the benefit of any immediate family member, family trust or other entity established for the benefit of the participant and/or an immediate family member thereof if we would be eligible to use a Form S-8 under the Securities Act of 1933, as amended, for the registration of the sale of the common stock subject to such award to the proposed transferee. Further, we are not required to recognize any such permitted transfer until such time as the permitted transferee has, as a condition to the transfer, delivered to us a written instrument in form and substance satisfactory to us confirming that such transferee will be bound by all of the terms and conditions of the award. None of the restrictions described in this paragraph prohibit a transfer from the participant to the Company.

No Rights as a Stockholder

No participant or designated beneficiary shall have any rights as a stockholder with respect to any shares of common stock to be distributed with respect to an award granted under the Amended Plan until becoming a record holder of such shares, subject to the terms of an award agreement.

Clawback

In accepting an award under the Amended Plan, a participant agrees to be bound by any clawback policy that the Company has in effect or may adopt in the future, including without limitation our Dodd-Frank Compensation Recovery Policy.**

<div align='center'>92</div>

Awards Granted under the Current Plan The following table sets forth information about equity-based awards granted under the Current Plan since adoption of the Current Plan through March 31, 2025, to the individuals and groups described in the below table.

| Name and Position                                                                                           |     | Number of Shares of     
 Common Stock            
 Underlying Stock Option 
 Granted                 |         |     | Number of Shares of     
 Common Stock            
 Underlying RSUs Granted |           |     | Number of Shares of         
 Common Stock                
 Underlying PSUs Granted (1) |         |
| Brian Goff, Chief Executive Officer                                                                         |     |                         | 338,000 |     |                         |    93,000 |     |                             | 132,000 |
| Cecilia Jones, Chief Financial Officer                                                                      |     |                         | 103,500 |     |                         |    44,910 |     |                             |  29,000 |
| James Burns, Chief Legal Officer                                                                            |     |                         | 103,500 |